Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone deacetylase 9 (HDAC9) is an enzyme that removes acetyl groups from lysine residues on histone and non-histone proteins, leading to altered gene expression. It plays roles in development, immunity, and disease. Dysregulation of HDAC9 is implicated in cancer and cardiovascular disease, making it a therapeutic target.
Inhibition of HDAC9
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone deacetylase 9 (HDAC9).